SAGE THERAPEUTICS INC.
1,622
USD
(-1.58%)
03/21/2025 - 16:35
Closed 15 min delayed data - NASDAQ Stocks
| Open: | 1,636 |
| Change: | -26 |
| Volume: | 153,297 |
| Low: | 1,622 |
| High: | 1,640 |
| High / Low range: | 18 |
| Type: | Stocks |
| Ticker: | SAGE |
| ISIN: |
SAGE THERAPEUTICS INC. news, videos and press releases
For more news please use our advanced search feature.
SAGE THERAPEUTICS INC. - More news...
SAGE THERAPEUTICS INC. - More news...
- 03/17/2025 - 18:10 SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc. - SAGE
- 02/11/2025 - 21:05 Sage Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results and Highlights Pipeline and Business Updates
- 01/28/2025 - 21:30 Sage Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 11, 2025
- 01/27/2025 - 14:20 Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal
- 01/12/2025 - 23:00 Sage Therapeutics to Present 2025 Strategic Focus at 43rd Annual J.P. Morgan Healthcare Conference
- 01/10/2025 - 23:49 Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen
- 01/08/2025 - 11:30 Sage Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
- 11/26/2024 - 12:00 Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
- 11/20/2024 - 11:30 Sage Therapeutics Announces Topline Results from the Phase 2 DIMENSION Study of Dalzanemdor (SAGE-718) in the Treatment of Cognitive Impairment Associated with Huntington’s Disease
- 10/28/2024 - 14:10 Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
- 10/28/2024 - 14:00 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- 10/28/2024 - 09:45 Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGE
- 10/26/2024 - 19:20 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/25/2024 - 16:00 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
- 10/25/2024 - 13:55 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
- 10/25/2024 - 00:02 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/23/2024 - 14:00 Sage Therapeutics Inc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SAGE
- 10/23/2024 - 09:45 Sage Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - SAGE
- 10/23/2024 - 03:05 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/21/2024 - 20:17 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/21/2024 - 09:49 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- 10/19/2024 - 15:15 INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
- 10/17/2024 - 17:41 SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sage Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - SAGE
- 10/17/2024 - 16:00 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/17/2024 - 09:45 Shareholders of Sage Therapeutics, Inc. Should Contact The Gross Law Firm Before October 28, 2024 to Discuss Your Rights - SAGE
- 10/15/2024 - 20:09 SAGE Investors Have Opportunity to Lead Sage Therapeutics, Inc. Securities Fraud Lawsuit
- 10/15/2024 - 09:45 Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
- 10/14/2024 - 14:15 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Sage Therapeutics
- 10/14/2024 - 09:55 Investors who lost money on Sage Therapeutics, Inc.(SAGE) should contact The Gross Law Firm about pending Class Action - SAGE
- 10/11/2024 - 10:00 Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - SAGE
